EMEA (Europe, Middle East and Africa) Active Pharma Ingredient Market Report 2017

October 2017 | 122 pages | ID: E4526DEB2FBPEN
QYResearch

Abstracts

In this report, the EMEA Active Pharma Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Active Pharma Ingredient for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Active Pharma Ingredient market competition by top manufacturers/players, with Active Pharma Ingredient sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Teva
• Novartis
• Pfizer
• Johnson & Johnson
• Mylan
• North China Pharmaceutical Group
• Dr. Reddy's Laboratories
• Roche
• Aurobindo pharma
• Sun Pharmaceutical Industries
• Boehringer Ingelheim GmbH
• Bayer
• BASF
• DSM
• Zhejiang Medicine
• Biocon
• Johnson Matthey
• Hisun Pharmacy
• Cambrex
• Shandong Xinhua Pharmaceutical
• Lonza group
• Huahai Pharmaceutical
• Haerbin Pharmaceutical Group
• Cipla
• Tian Yao
• Lupin
• North East Pharmaceutical
• Albemarle
• Shandong Lukang Pharmaceutical
• Jiangsu Hengrui Medicine

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Innovative Active Pharmaceutical Ingredients
• Generic Active Pharmaceutical Ingredients

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Active Pharma Ingredient for each application, including

• Oncology
• Cardiovascular Disease
• Diabetes
• Central Nervous System and Neurological Disorders
• Endocrinology
• Other Therapeutic Applications

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Active Pharma Ingredient Market Report 2017

1 ACTIVE PHARMA INGREDIENT OVERVIEW

1.1 Product Overview and Scope of Active Pharma Ingredient
1.2 Classification of Active Pharma Ingredient
  1.2.1 EMEA Active Pharma Ingredient Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Active Pharma Ingredient Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Innovative Active Pharmaceutical Ingredients
  1.2.4 Generic Active Pharmaceutical Ingredients
1.3 EMEA Active Pharma Ingredient Market by Application/End Users
  1.3.1 EMEA Active Pharma Ingredient Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Oncology
  1.3.3 Cardiovascular Disease
  1.3.4 Diabetes
  1.3.5 Central Nervous System and Neurological Disorders
  1.3.6 Endocrinology
  1.3.7 Other Therapeutic Applications
1.4 EMEA Active Pharma Ingredient Market by Region
  1.4.1 EMEA Active Pharma Ingredient Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Active Pharma Ingredient (2012-2022)
  1.5.1 EMEA Active Pharma Ingredient Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Active Pharma Ingredient Revenue and Growth Rate (2012-2022)

2 EMEA ACTIVE PHARMA INGREDIENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Active Pharma Ingredient Market Competition by Players/Manufacturers
  2.1.1 EMEA Active Pharma Ingredient Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Active Pharma Ingredient Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Active Pharma Ingredient Sale Price by Players (2012-2017)
2.2 EMEA Active Pharma Ingredient (Volume and Value) by Type/Product Category
  2.2.1 EMEA Active Pharma Ingredient Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Active Pharma Ingredient Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Active Pharma Ingredient Sale Price by Type (2012-2017)
2.3 EMEA Active Pharma Ingredient (Volume) by Application
2.4 EMEA Active Pharma Ingredient (Volume and Value) by Region
  2.4.1 EMEA Active Pharma Ingredient Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Active Pharma Ingredient Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Active Pharma Ingredient Sales Price by Region (2012-2017)

3 EUROPE ACTIVE PHARMA INGREDIENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Active Pharma Ingredient Sales and Value (2012-2017)
  3.1.1 Europe Active Pharma Ingredient Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Active Pharma Ingredient Revenue and Growth Rate (2012-2017)
3.2 Europe Active Pharma Ingredient Sales and Market Share by Type
3.3 Europe Active Pharma Ingredient Sales and Market Share by Application
3.4 Europe Active Pharma Ingredient Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Active Pharma Ingredient Sales Volume by Countries (2012-2017)
  3.4.2 Europe Active Pharma Ingredient Revenue by Countries (2012-2017)
  3.4.3 Germany Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  3.4.4 France Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  3.4.5 UK Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  3.4.6 Russia Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  3.4.7 Italy Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Active Pharma Ingredient Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ACTIVE PHARMA INGREDIENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Active Pharma Ingredient Sales and Value (2012-2017)
  4.1.1 Middle East Active Pharma Ingredient Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Active Pharma Ingredient Revenue and Growth Rate (2012-2017)
4.2 Middle East Active Pharma Ingredient Sales and Market Share by Type
4.3 Middle East Active Pharma Ingredient Sales and Market Share by Application
4.4 Middle East Active Pharma Ingredient Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Active Pharma Ingredient Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Active Pharma Ingredient Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  4.4.4 Israel Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  4.4.5 UAE Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  4.4.6 Iran Active Pharma Ingredient Sales and Growth Rate (2012-2017)

5 AFRICA ACTIVE PHARMA INGREDIENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Active Pharma Ingredient Sales and Value (2012-2017)
  5.1.1 Africa Active Pharma Ingredient Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Active Pharma Ingredient Revenue and Growth Rate (2012-2017)
5.2 Africa Active Pharma Ingredient Sales and Market Share by Type
5.3 Africa Active Pharma Ingredient Sales and Market Share by Application
5.4 Africa Active Pharma Ingredient Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Active Pharma Ingredient Sales Volume by Countries (2012-2017)
  5.4.2 Africa Active Pharma Ingredient Revenue by Countries (2012-2017)
  5.4.3 South Africa Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Active Pharma Ingredient Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Active Pharma Ingredient Sales and Growth Rate (2012-2017)

6 EMEA ACTIVE PHARMA INGREDIENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Teva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharma Ingredient Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Active Pharma Ingredient Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Active Pharma Ingredient Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Active Pharma Ingredient Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Active Pharma Ingredient Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 North China Pharmaceutical Group
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Active Pharma Ingredient Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Dr. Reddy?s Laboratories
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Active Pharma Ingredient Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dr. Reddy?s Laboratories Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Active Pharma Ingredient Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Aurobindo pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Active Pharma Ingredient Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sun Pharmaceutical Industries
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Active Pharma Ingredient Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim GmbH
6.12 Bayer
6.13 BASF
6.14 DSM
6.15 Zhejiang Medicine
6.16 Biocon
6.17 Johnson Matthey
6.18 Hisun Pharmacy
6.19 Cambrex
6.20 Shandong Xinhua Pharmaceutical
6.21 Lonza group
6.22 Huahai Pharmaceutical
6.23 Haerbin Pharmaceutical Group
6.24 Cipla
6.25 Tian Yao
6.26 Lupin
6.27 North East Pharmaceutical
6.28 Albemarle
6.29 Shandong Lukang Pharmaceutical
6.30 Jiangsu Hengrui Medicine

7 ACTIVE PHARMA INGREDIENT MANUFACTURING COST ANALYSIS

7.1 Active Pharma Ingredient Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharma Ingredient

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharma Ingredient Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ACTIVE PHARMA INGREDIENT MARKET FORECAST (2017-2022)

11.1 EMEA Active Pharma Ingredient Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Active Pharma Ingredient Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Active Pharma Ingredient Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Active Pharma Ingredient Price and Trend Forecast (2017-2022)
11.2 EMEA Active Pharma Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Active Pharma Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Active Pharma Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Active Pharma Ingredient Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Active Pharma Ingredient Sales Forecast by Type (2017-2022)
11.7 EMEA Active Pharma Ingredient Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Active Pharma Ingredient
Figure EMEA Active Pharma Ingredient Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Active Pharma Ingredient Sales Volume Market Share by Type (Product Category) in 2016
Figure Innovative Active Pharmaceutical Ingredients Product Picture
Figure Generic Active Pharmaceutical Ingredients Product Picture
Figure EMEA Active Pharma Ingredient Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Active Pharma Ingredient by Application in 2016
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiovascular Disease Examples
Table Key Downstream Customer in Cardiovascular Disease
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Central Nervous System and Neurological Disorders Examples
Table Key Downstream Customer in Central Nervous System and Neurological Disorders
Figure Endocrinology Examples
Table Key Downstream Customer in Endocrinology
Figure Other Therapeutic Applications Examples
Table Key Downstream Customer in Other Therapeutic Applications
Figure EMEA Active Pharma Ingredient Market Size (Million USD) by Region (2012-2022)
Figure Europe Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Active Pharma Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Active Pharma Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure Africa Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Active Pharma Ingredient Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Active Pharma Ingredient Sales Volume and Growth Rate (2012-2022)
Figure EMEA Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Active Pharma Ingredient Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Active Pharma Ingredient Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Active Pharma Ingredient Sales Share by Players (2012-2017)
Figure 2016 Active Pharma Ingredient Sales Share by Players
Figure 2017 Active Pharma Ingredient Sales Share by Players
Figure EMEA Active Pharma Ingredient Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Active Pharma Ingredient Revenue (Million USD) by Players (2012-2017)
Table EMEA Active Pharma Ingredient Revenue Share by Players (2012-2017)
Table 2016 EMEA Active Pharma Ingredient Revenue Share by Players
Table 2017 EMEA Active Pharma Ingredient Revenue Share by Players
Table EMEA Active Pharma Ingredient Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Active Pharma Ingredient Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Active Pharma Ingredient Sales Share by Type (2012-2017)
Figure Sales Market Share of Active Pharma Ingredient by Type (2012-2017)
Figure EMEA Active Pharma Ingredient Sales Market Share by Type (2012-2017)
Table EMEA Active Pharma Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Active Pharma Ingredient Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Active Pharma Ingredient by Type in 2016
Table EMEA Active Pharma Ingredient Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Active Pharma Ingredient Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Active Pharma Ingredient Sales Share by Application (2012-2017)
Figure Sales Market Share of Active Pharma Ingredient by Application (2012-2017)
Figure EMEA Active Pharma Ingredient Sales Market Share by Application in 2016
Table EMEA Active Pharma Ingredient Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Active Pharma Ingredient Sales Share by Region (2012-2017)
Figure Sales Market Share of Active Pharma Ingredient by Region (2012-2017)
Figure EMEA Active Pharma Ingredient Sales Market Share in 2016
Table EMEA Active Pharma Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Active Pharma Ingredient Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Active Pharma Ingredient by Region (2012-2017)
Figure EMEA Active Pharma Ingredient Revenue Market Share Regions in 2016
Table EMEA Active Pharma Ingredient Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Active Pharma Ingredient Revenue and Growth Rate (2012-2017)
Table Europe Active Pharma Ingredient Sales (K Units) by Type (2012-2017)
Table Europe Active Pharma Ingredient Market Share by Type (2012-2017)
Figure Europe Active Pharma Ingredient Market Share by Type in 2016
Table Europe Active Pharma Ingredient Sales (K Units) by Application (2012-2017)
Table Europe Active Pharma Ingredient Market Share by Application (2012-2017)
Figure Europe Active Pharma Ingredient Market Share by Application in 2016
Table Europe Active Pharma Ingredient Sales (K Units) by Countries (2012-2017)
Table Europe Active Pharma Ingredient Sales Market Share by Countries (2012-2017)
Figure Europe Active Pharma Ingredient Sales Market Share by Countries (2012-2017)
Figure Europe Active Pharma Ingredient Sales Market Share by Countries in 2016
Table Europe Active Pharma Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Europe Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Europe Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Europe Active Pharma Ingredient Revenue Market Share by Countries in 2016
Figure Germany Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure France Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure UK Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Active Pharma Ingredient Sales (K Units) by Type (2012-2017)
Table Middle East Active Pharma Ingredient Market Share by Type (2012-2017)
Figure Middle East Active Pharma Ingredient Market Share by Type (2012-2017)
Table Middle East Active Pharma Ingredient Sales (K Units) by Applications (2012-2017)
Table Middle East Active Pharma Ingredient Market Share by Applications (2012-2017)
Figure Middle East Active Pharma Ingredient Sales Market Share by Application in 2016
Table Middle East Active Pharma Ingredient Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Active Pharma Ingredient Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Active Pharma Ingredient Sales Volume Market Share by Countries in 2016
Table Middle East Active Pharma Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Middle East Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Middle East Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Middle East Active Pharma Ingredient Revenue Market Share by Countries in 2016
Figure Saudi Arabia Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Active Pharma Ingredient Sales (K Units) by Type (2012-2017)
Table Africa Active Pharma Ingredient Sales Market Share by Type (2012-2017)
Figure Africa Active Pharma Ingredient Sales Market Share by Type (2012-2017)
Figure Africa Active Pharma Ingredient Sales Market Share by Type in 2016
Table Africa Active Pharma Ingredient Sales (K Units) by Application (2012-2017)
Table Africa Active Pharma Ingredient Sales Market Share by Application (2012-2017)
Figure Africa Active Pharma Ingredient Sales Market Share by Application (2012-2017)
Table Africa Active Pharma Ingredient Sales Volume (K Units) by Countries (2012-2017)
Table Africa Active Pharma Ingredient Sales Market Share by Countries (2012-2017)
Figure Africa Active Pharma Ingredient Sales Market Share by Countries (2012-2017)
Figure Africa Active Pharma Ingredient Sales Market Share by Countries in 2016
Table Africa Active Pharma Ingredient Revenue (Million USD) by Countries (2012-2017)
Table Africa Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Africa Active Pharma Ingredient Revenue Market Share by Countries (2012-2017)
Figure Africa Active Pharma Ingredient Revenue Market Share by Countries in 2016
Figure South Africa Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Table Teva Active Pharma Ingredient Basic Information List
Table Teva Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Teva Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Novartis Active Pharma Ingredient Basic Information List
Table Novartis Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Novartis Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Pfizer Active Pharma Ingredient Basic Information List
Table Pfizer Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Pfizer Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Active Pharma Ingredient Basic Information List
Table Johnson & Johnson Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Mylan Active Pharma Ingredient Basic Information List
Table Mylan Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Mylan Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table North China Pharmaceutical Group Active Pharma Ingredient Basic Information List
Table North China Pharmaceutical Group Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure North China Pharmaceutical Group Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure North China Pharmaceutical Group Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure North China Pharmaceutical Group Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Dr. Reddy?s Laboratories Active Pharma Ingredient Basic Information List
Table Dr. Reddy?s Laboratories Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy?s Laboratories Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy?s Laboratories Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Dr. Reddy?s Laboratories Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Roche Active Pharma Ingredient Basic Information List
Table Roche Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Roche Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Aurobindo pharma Active Pharma Ingredient Basic Information List
Table Aurobindo pharma Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aurobindo pharma Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Aurobindo pharma Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Aurobindo pharma Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceutical Industries Active Pharma Ingredient Basic Information List
Table Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharma Ingredient Sales Market Share in EMEA (2012-2017)
Figure Sun Pharmaceutical Industries Active Pharma Ingredient Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Active Pharma Ingredient Basic Information List
Table Bayer Active Pharma Ingredient Basic Information List
Table BASF Active Pharma Ingredient Basic Information List
Table DSM Active Pharma Ingredient Basic Information List
Table Zhejiang Medicine Active Pharma Ingredient Basic Information List
Table Biocon Active Pharma Ingredient Basic Information List
Table Johnson Matthey Active Pharma Ingredient Basic Information List
Table Hisun Pharmacy Active Pharma Ingredient Basic Information List
Table Cambrex Active Pharma Ingredient Basic Information List
Table Shandong Xinhua Pharmaceutical Active Pharma Ingredient Basic Information List
Table Lonza group Active Pharma Ingredient Basic Information List
Table Huahai Pharmaceutical Active Pharma Ingredient Basic Information List
Table Haerbin Pharmaceutical Group Active Pharma Ingredient Basic Information List
Table Cipla Active Pharma Ingredient Basic Information List
Table Tian Yao Active Pharma Ingredient Basic Information List
Table Lupin Active Pharma Ingredient Basic Information List
Table North East Pharmaceutical Active Pharma Ingredient Basic Information List
Table Albemarle Active Pharma Ingredient Basic Information List
Table Shandong Lukang Pharmaceutical Active Pharma Ingredient Basic Information List
Table Jiangsu Hengrui Medicine Active Pharma Ingredient Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharma Ingredient
Figure Manufacturing Process Analysis of Active Pharma Ingredient
Figure Active Pharma Ingredient Industrial Chain Analysis
Table Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2016
Table Major Buyers of Active Pharma Ingredient
Table Distributors/Traders List
Figure EMEA Active Pharma Ingredient Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Active Pharma Ingredient Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Active Pharma Ingredient Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Active Pharma Ingredient Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Active Pharma Ingredient Sales Market Share Forecast by Region (2017-2022)
Table EMEA Active Pharma Ingredient Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Active Pharma Ingredient Revenue Market Share Forecast by Region (2017-2022)
Table Europe Active Pharma Ingredient Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Active Pharma Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Europe Active Pharma Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Active Pharma Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Active Pharma Ingredient Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Active Pharma Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Active Pharma Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Active Pharma Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Active Pharma Ingredient Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Active Pharma Ingredient Sales Market Share Forecast by Countries (2017-2022)
Table Africa Active Pharma Ingredient Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Active Pharma Ingredient Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Active Pharma Ingredient Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Active Pharma Ingredient Sales Market Share Forecast by Type (2017-2022)
Table EMEA Active Pharma Ingredient Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Active Pharma Ingredient Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources